Shijiazhuang Yiling Pharmaceutical Co.,Ltd



Quote for Shijiazhuang Yiling Pharmaceutical Co.,Ltd

Last Trade:
-
Change:
--
Symbol/Code:
002603
Status:
-
Stock Type:
A Share
Market Cap:
-
Open:
-
Prev Close:
-
Bid:
-
Ask:
-
Volume(*100):
-
Amount:
-
Limit Up:
-
Limit Down:
-
Day's Range:
-
P/E(ttm):
-
P/B ratio
-
Update:-
Currency in CNY Time=UTC+8002603 quote

Summary for Shijiazhuang Yiling Pharmaceutical Co.,Ltd

SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD is principally engaged in the research, development, manufacture and distribution of Chinese patent medicines. The Company provides prescription medicines and over the counter (OTC) medicines, such as medicines for cardio-cerebral vascular diseases, medicines for cold, medicines for diabetes, medicines for kidney and mind-easing medicines, among others, including granules, capsules and oral liquid. During the year ended December 31, 2010, the Company obtained approximately 92.26% of its total revenue from medicines for cardio-cerebral vascular diseases. The Company distributes its products primarily in domestic market.

Profile for Shijiazhuang Yiling Pharmaceutical Co.,Ltd

Full Name:Shijiazhuang Yiling Pharmaceutical Co.,Ltd
Full Name in Chinese:石家庄以岭药业股份有限公司 Short Name in Chinese:以岭药业
Symbol/Stock Code:
002603
Listed in:
Shenzhen Stock Exchange
Issued Capital
-
Negotiable Capital:
-
Chairman:
Wu Yiling
Secretary of the Board:
Wu Rui
Phone:
+86-311-85901311
Fax:
+86-311-85901311
Official Website:www.yiling.cn
E-mail:wurui@yiling.cn
Address:No. 238,Tianshan Avenue, High-Tech Ind,SHIJIAZHUANG HEB 050035
IPO Subscription Date:
2011-07-19
Listing Date:
2011-07-28
IPO Issued Capital:
65000000
IPO Price:
34.56 CNY
IPO fees:
90006000 CNY
Money Raised by IPO:
2246400000 CNY
IPO Par Value:
1.00 CNY
Net Money Raised:
2156394000 CNY
Open(Listing day):
40.99 CNY
Close(Listing day):
44.68 CNY
Diluted P/E ratio after IPO:
47.3900
Turnover rate(listing day):
88.05%

Financials for Shijiazhuang Yiling Pharmaceutical Co.,Ltd

UPDATE:2012-10-26 Annual Report Abstract:(All Currency In CNY)

Indicators/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Net Profit(after tax)(Million)
160.4639
454.0711
315.5591
297.1828
Net Profit Growth(%)
-45.73
43.89
6.18
143.35
Return On Equity(ROE)(%)
4.20
12.27
28.92
37.73
Debt ratio(%)
11.59
12.39
38.39
47.62
Net Operating Cash Flow/Net Profit(%)
-9.03
-89.96
94.98
107.08

Per Share Financial Data:(All Currency In CNY)

Per Share Indicators/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Earnings Per Share(EPS)
0.2900
1.1700
0.9400
0.9000
Diluted Earnings Per Share
0.0000
1.0800
0.9200
0.9200
Net Asset Value Per Share (NAVPS)
6.9100
8.7100
3.0300
2.1880
Additional Paid-In Capital Per Share
3.6606
5.0587
0.1627
0.2095
Retained Earnings Per Share
2.0069
2.3315
1.5886
1.5682
Net Cash Flow From Operatings Activities Per Share
-0.0300
-0.9600
0.8300
0.8800
Net Cash Flow Per Share
-0.6581
3.6692
0.5340
0.2353

Balance Sheet:(All Currency In CNY)

Assets And Liabilities/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Total Assets(Million)
4320.3728
4225.4173
1771.1113
1509.4405
Total Liabilities(Million)
500.7341
523.7755
680.077
718.8927
Current Liabilities(Million)
296.7484
373.9797
534.1
640.7512
Long Term Liabilities(Million)
-
-
-
-
Cash And Cash Equivalents(Million)
1598.889
1962.4991
403.0912
210.8362
Accounts Receivables(Million)
212.0247
184.794
167.5221
167.6831
Deposit Received(Million)
43.3876
28.8016
45.2613
60.5815
Other Receivables(Million)
244.9453
30.6389
1.2375
192.1344
Bad Debt Reserve(Million)
-
-
-
-
Shareholder's Equity/Owner's Equity(Million)
3819.6387
3701.6418
1091.0343
787.6866
Debt ratio(%)
11.59
12.39
38.39
47.62
Equity Ratio(%)
88.4000
87.6000
61.6000
52.1800
Current Ratio
10.0228
8.5100
1.6716
1.4495
Quick Ratio
8.4627
7.6363
1.2782
1.2241

Cash Flow Statement:(All Currency In CNY)

Cash Flow/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Cash From Selling Commodities(Million)
1280.3543
1539.7431
1917.8441
1817.1786
Net Cash Flow From Operatings Activities(Million)
-14.491
-408.4861
299.7178
318.2113
Net Cash Flow From Operatings Activities Change(%)
-93.71
-236.29
-5.81
51.40
Net Cash Flow(Million)
-363.6101
1559.4079
192.255
84.7062
Cash From Selling Commodities/Prime Revenue(%)
120.43
78.83
116.28
111.32
Net Cash Flow/Net Profit(%)
-226.60
343.43
60.93
28.50
Cash Flow From Investing Activities(Million)
-211.5718
-177.8829
-307.1532
-210.5699
Cash Flow From Financing Activities(Million)
-137.5685
2145.7444
199.6904
-22.9352

Income Statement:(All Currency In CNY)

Income Indicators/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Prime Operating Revenue(Million)
1063.1178
1953.2114
1649.3201
1632.331
Prime Operating Profit(Million)
-
-
-
-
Operating Costs(Million)
429.7898
638.0108
571.3868
528.4406
Administrative Costs(Million)
133.1097
183.1163
153.5896
101.9069
Financing Costs(Million)
-33.0923
-6.2276
6.1777
1.0691
Above Three Costs Change(%)
-8.59
11.45
15.80
60.52
Operating Profit(Million)
171.3972
489.5882
345.7188
339.639
Income From Investment(Million)
-
-
-
-
Government Subsidies(Million)
-
-
-
-
Net Non-Operating Income And Expense(Million)
17.6621
42.9156
23.0425
14.6743
Total Profit(Million)
189.0593
532.5038
368.7613
354.3133
Corporate Income Tax(Million)
28.5954
78.4327
53.7357
56.7981
Net Profit(Million)
160.4639
454.0711
315.5591
297.1828
Gross Profit Ratio(%)
68.24
68.37
66.36
60.98
Operating Margin(%)
16.12
25.06
20.96
20.80
Return On Equity(ROE)(%)
4.20
12.27
28.92
37.73

Announcements for Shijiazhuang Yiling Pharmaceutical Co.,Ltd

Date: 2012-08-14
Title: EGM RESOLUTION
The Company held its 1st Extraordinary General Meeting of 2012 on 11 August 2012, during which the following proposal(s) was/were approved:
1. Amendments to the Company's articles of association
Date: 2012-07-27
Title: EGM-SPOT
The Company will hold the 1st Extraordinary General Meeting of 2012 at 09:00 on 11 August 2012.

Meeting agenda:
1 Amendments to the Company's articles of association


Meeting attendees:
1. A-share holders registered at CSDCC Shenzhen after the close of trading on 06 August 2012 are entitled to vote. Original notarized power of attorney for voting is required.
2. Directors of the board, supervisors of the supervisory committee, senior executives and appointed lawyers are entitled to attend the meeting.

Registration period: 10 August 2012
Date: 2012-06-04
Title: DIVIDEND IMPLEMENTATION (CASH AND BONUS ISSUE)
2011 final distribution plan to be implemented (A shares):

1. Cash dividend/10 shares (tax included): CNY1.00000000
2. Bonus issue from profit (share/10 shares): none
3. Bonus issue from capital reserve (share/10 shares): 3.0000


Record date: 08 June 2012
Ex-date: 11 June 2012
Payment date: 11 June 2012
Listing date of the bonus issues: 11 June 2012.
10 percent withholding tax on cash dividend will be deducted in CNY within the cash dividend receivable. Please refer to below details:
Tax on cash dividend/10 shares: CNY0.10000000(10 percent x CNY1.00000000)
Net cash dividend/10 shares after tax: CNY0.90000000(CNY1.00000000- CNY0.10000000)
Date: 2012-04-20
Title: AGM RESOLUTION
The Company held its Annual General Meeting of 2011 on 19 April 2012, during which the following proposal(s) was/were approved:
1. 2011 work report of the board of directors
2. 2011 work report of the supervisory committee
3. 2011 annual report and its summary
4. 2011 financial resolution report
5. 2011 profit distribution plan
6. Appointment of audit firm
7. Amendments to the Company's articles of association
8. Adjustment to the remuneration standard for supervisors
The detailed profit distribution plan are as follows:
1) Cash dividend/10 shares (tax included): CNY1.00000000
2) Bonus issue from profit (share/10 shares): none
3) Bonus issue from capital reserve (share/10 shares): 3.00.
Date: 2012-03-30
Title: FINAL DIVIDEND
The Company issued its 2011 annual report on 30 March 2012.

The profit distribution proposal for 2011:
1. Cash dividend/10 shares (tax included): CNY1.00000000
2. Bonus issue from profit (share/10 shares):none
3. Bonus issue from capital reserve (share/10 shares):3.0000.
Date: 2012-03-30
Title: AGM-SPOT
The Company will hold the 2011 Annual General Meeting at 08:00 on 19 April 2012.

Meeting agenda:
1. 2011 work report of the board of directors
2. 2011 work report of the supervisory committee
3. 2011 annual report and its summary
4. 2011 financial resolution report
5. 2011 profit distribution plan
6. Appointment of audit firm
7. Amendments to the Company's articles of association
8. Adjustment to the remuneration standard for supervisors
The detailed profit distribution plan are as follows:
1) Cash dividend/10 shares (tax included): CNY1.00000000
2) Bonus issue from profit (share/10 shares): none
3) Bonus issue from capital reserve (share/10 shares): 3.0000

Meeting attendees:
1. A-share holders registered at CSDCC Shenzhen after the close of trading on 11 April 2012 are entitled to vote. Original notarized power of attorney for voting is required.
2. Directors of the board, supervisors of the supervisory committee, senior executives and appointed lawyers are entitled to attend the meeting.

Registration period: 17 April 2012
Date: 2011-10-25
Title: PLACING SHARE LISTING
The Company's 13 million A-shares placed to the institutional investors through offline placement will reach the 3-month lock-up period and be listed on the Shenzhen Stock Exchange as of 28 October 2011.
Date: 2011-07-27
Title: IPO SHARE LISTING
THE CO ISSUED A TOTAL OF 65 MILLION SHARES (CODE:002603) IN ITS INITIAL PUBLIC OFFERING. OF THE SHARES,52 MILLION SHARES WILL BE LISTED ON THE SHENZHEN STOCK EXCHANGE ON 28JUL11 WHILE THE REMAINDER WILL BECOME TRADABLE THREE MONTHS LATER.
Date: 2011-07-18
Title: IPO-ONLINE SUBSCRIPTION
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. HAS BEEN APPROVED BY THE CHINA SECURITIES REGULATORY COMMISSION (THE CSRC) TO ISSUE 65.000000 MILLION A-SHARES IN ITS INITIAL PUBLIC OFFERING.
1. CLASS: A SHARES
2. STOCK CODE: 002603
3. STOCK ABBREVIATION: YILING PHARMACEUTICAL
4. ISSUING VOLUME: 65.000000 MILLION SHARES
5. PAR VALUE: CNY1.00 PER SHARE
6. ISSUING MECHANISM: A BOOK BUILDING PROCESS WILL BE CONDUCTED WITH A COMBINATION OF ONLINE PUBLIC OFFERING AND OFFLINE PLACEMENT.
7. TARGETED LISTING BOURSE: SHENZHEN STOCK EXCHANGE
8. OFFLINE PLACEMENT VOLUME:13.000000 MILLION SHARES
9. ONLINE OFFERING VOLUME: 52.000000 MILLION SHARES
10. PRICE: CNY34.56 PER SHARE
11. OFFLINE SUBSCRIPTION PERIOD:19JUL11
12. ONLINE SUBSCRIPTION DATE: 19JUL11
Date: 2011-07-11
Title: IPO
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. HAS BEEN APPROVED BY THE CHINA SECURITIES REGULATORY COMMISSION (THE CSRC) TO ISSUE 65.0000 MILLION A-SHARES IN ITS INITIAL PUBLIC OFFERING, WHICH IS STRUCTURED AS FOLLOWS:
1.CLASS: A SHARES
2.SIZE: 65.0000 MILLION SHARES
3.PAR VALUE: CNY1.00 PER SHARE
4.ISSUING MECHANISM: A BOOK BUILDING PROCESS WILL BE CONDUCTED WITH A COMBINATION OF ONLINE PUBLIC OFFERING AND OFFLINE PLACEMENT.
5.TARGETED LISTING BOURSE: SHENZHEN STOCK EXCHANGE
6.OFFLINE PLACEMENT VOLUME: 13.0000 MILLION SHARES
7.ONLINE OFFERING VOLUME:52.0000 MILLION SHARES
8.IPO PRICE INQUIRY PERIOD: FROM 12JUL11 TO 14JUL11
9.IPO PRICE DETERMINED: 18JUL11
10.OFFLINE SUBSCRIPTION DATE:19JUL11
11.ONLINE SUBSCRIPTION DATE: 19JUL11
12.EXPECTED LISTING DATE:N/A